reports
- David Barden
- Vikash Harlalka
Broadband cNPS comparisons by tech & operator - The latest data availa...
Scouring the data in this report, we’d point you to the appendix for a quick review. What stands out is that when a broadband customer interacts with a sales rep, presumably they are doing so with a problem or request that an automated or AI-driven IVR cannot address. Almost without fail, sales rep interactions are the Achilles heal of the market right now and likely a core reason, care scores suffer. The operator that can solve this puzzle, and it could be cable, has a window to shift their rel...
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Qua...
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results Initial clinical data for CLN-978 in SLE and RA confirmed for Q2 2026; repeat dosing data in RA confirmed for Q3 2026 Zipalertinib rolling NDA submission completed; enrollment of REZILIENT3 frontline study completed with top-line results available by year-end 2026 Cash and investments of $439.0 million as of December 31, 2025; runway into 2029 CAMBRIDGE, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerat...
- Geoffrey Von Der Ahe
- Robert Driscoll
- Jonathan Moreland
CSGP COSTAR GROUP INC
XRAY DENTSPLY SIRONA INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
SFM SPROUTS FARMERS MARKETS INC.
NWBI NORTHWEST BANCSHARES INC.
MYGN MYRIAD GENETICS INC.
FFIN FIRST FINANCIAL BANKSHARES INC
COTY COTY INC. CLASS A
NXRT NEXPOINT RESIDENTIAL TRUST INC.
WHF WHITEFIELD
ORN ORION GROUP HOLDINGS
THO THOR INDUSTRIES INC.
TTEC TELETECH HOLDINGS
HOG INC.
GO HARLEY-DAVIDSON INC.
ALT GROCERY OUTLET HOLDING
TSLX ALTIMMUNE INC
VERX SIXTH STREET SPECIALTY LENDING
ADV INC.
TKNO VERTEX
AIRS INC.
QSI ADVANTAGE SOLUTIONS INC (A)
FRST ALPHA TEKNOVA
TCBX INC.
EBC AIRSCULPT TECHNOLOGIES INC
NBBK QUANTUM-SI INC
MXF PRIMIS FINANCIAL CORP
LYEL THIRD COAST BANCSHARES INC
EASTERN BANKSHARES INC
NB BANCORP INC.
THE MEXICO FUND
INC.
LYELL IMMUNOPHARMA INC.
Comstock Resources Inc: 1 director
A director at Comstock Resources Inc sold 48,915 shares at 21.205USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
EQT Corp: 1 director
A director at EQT Corp sold/sold after exercising options 20,000 shares at 60.690USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
MediWound Files Annual Report on Form 20-F
MediWound Files Annual Report on Form 20-F MediWound Files Annual Report on Form 20-F YAVNE, Israel, March 5, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the “SEC”) on March 5, 2026. The annual report can be accessed on the SEC’s website at , as well as via the Company’s investor relations website at . The Company will provide a hard copy of its annual report o...
Amneal to Participate in Upcoming Investor Conference
Amneal to Participate in Upcoming Investor Conference BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat at the following upcoming investor conference: Barclays 28th Annual Global Healthcare ConferenceDate: March 10, 2026Fireside Chat: Tuesday, March 10, 2026, at 11:00AM ESTLocation: Miami, FL A webcast of the presentation will be available on Amneal’s Investor Relations website at . A replay of the webcast will be available following th...
Moody's Ratings assigns Baa2 rating to Hasbro's new senior unsecured n...
Moody's Ratings (Moody's) today assigned a Baa2 rating to Hasbro, Inc.'s ("Hasbro") new senior unsecured notes. All other ratings, including the Baa2 senior unsecured and Prime-2 commercial paper ratings remain unchanged. The stable outlook remains unchanged. Hasbro plans to issue up to $400 milli...
Range Resources Corp : 2 directors
Two Directors at Range Resources Corp sold after exercising options/gave away/sold 54,376 shares at between 0.000USD and 41.995USD. The significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tr...
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results EscharEx® Phase III VALUE trial advancing as planned Expanded NexoBrid® manufacturing facility operational; regulatory approvals expected in 2026 $17 million revenue in 2025; $54 million in cash at year-end; 2026–2028 revenue guidance reaffirmed Conference Call Today, March 5, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, March 05, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for...
- David Barden
- Vikash Harlalka
Broadband Spring 2026 – A fine time for FWA
In this Broadband Spring report, we share a quick update on broadband industry trends from 4Q25 heading into 2026E. Industry net adds improved meaningfully in 4Q25 from a year ago but remained slightly below last year when we adjust for the loss of ACP. Net adds for the quarter were in line with the pre-pandemic norm but trailing twelve-month net adds remain below pre-pandemic levels. We take a deep-dive here into FWA’s continued strong momentum, by carrier, and how it fits into the overall broa...
Synchrony Financial: 8 directors
Eight Directors at Synchrony Financial sold after exercising options/sold 336,304 shares at between 67.160USD and 68.681USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
Orion Group Holdings Reports 4th Quarter and Full Year 2025 Results an...
Orion Group Holdings Reports 4th Quarter and Full Year 2025 Results and Initiation of 2026 Guidance HOUSTON, March 03, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company” or “Orion”), a leading specialty construction company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the year ended December 31, 2025: ($ in millions, except EPS) Revenue of $852 million, GAAP net income of $2.5 million or $0.06 per diluted share, Adjusted EBITDA of $45 million and Adjusted EPS of $0.25 per diluted shareCash ...
- David Barden
SATS: Raising PT to $147 on adjusted SpaceX assumptions and Echostar u...
We are updating our SATS valuation to reflect 1) an updated SpaceX valuation, and 2) updated SATS’ share of SpaceX following the merger between SpaceX and xAI. We now value SpaceX at $1.25Tn for the purpose of SATS valuation. In Elon we trust. We are raising our SATS price target to $147, up from $125 previously.
- David Barden
SATS 4Q25 Quick Take: It’s all about the call
SATS reported 4Q with a few surprises both positive and negative. On the plus side SlingTV losses were better than expected and wireless EBITDA loss was much better than expected. We will discuss more on the call, but Sling was likely a function of 4Q promo pricing and wireless was a function of not paying tower companies. The negative was that after several quarters of positive wireless net adds, SATS swung to a loss in 4Q, reflecting the competitive nature of the quarter. As always, the market...
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Resul...
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Clinical development for both the investigational CD47-inhibitor evorpacept and the novel EGFR-targeted antibody-drug conjugate ALX2004 remains on track following strong 2025 execution; company anticipates multiple meaningful data sets and milestones in the coming 12 to 18 months - - Evorpacept biomarker strategy validated by data from both the Phase 2 ASPEN-06 gastric cancer trial and the Phase 1b/2 breast cancer trial, independently suggesting CD47 overexpression is predictive of evor...
Range Increases Quarterly Dividend By 11%
Range Increases Quarterly Dividend By 11% FORT WORTH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the first quarter. A dividend of $0.10 per common share is payable on March 27, 2026 to stockholders of record at the close of business on March 13, 2026. This represents an 11% increase to Range’s quarterly cash dividend and provides an annualized dividend of $0.40 per share. RANGE RESOURCES CORPORATION (NYSE: RRC) is a leading U.S. independent natural ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.